SCHEMBL30906536

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC

nearest known ligand 0.71

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	13/20	0.71

▸	NPBWR1	P48145	5/20	0.61

▸	ECE1	P42892	1/20	0.61

▸	MUS81	Q96NY9	1/20	0.61

▸	IL23R	Q5VWK5	1/20	0.60

▸	RXFP1	Q9HBX9	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906516	0.99	GLP1R (0.72)	GLP1RNPBWR1ECE1MUS81IL23R
SCHEMBL30906465	0.99	GLP1R (0.72)	GLP1RNPBWR1ECE1MUS81IL23R
SCHEMBL30906493	0.98	GLP1R (0.70)	GLP1RNPBWR1ECE1MUS81IL23R
SCHEMBL30906486	0.98	GLP1R (0.70)	GLP1RNPBWR1ECE1MUS81IL23R
SCHEMBL30906511	0.96	GLP1R (0.71)	GLP1RECE1MUS81IL23R
SCHEMBL30906532	0.96	GLP1R (0.71)	GLP1RECE1MUS81IL23R
SCHEMBL30906503	0.96	GLP1R (0.72)	GLP1RNPBWR1ECE1MUS81
SCHEMBL30906488	0.95	GLP1R (0.66)	GLP1RNPBWR1ECE1MUS81IL23R
SCHEMBL31000949	0.94	GLP1R (0.75)	GLP1RECE1MUS81
SCHEMBL30906555	0.94	GLP1R (0.68)	GLP1RECE1MUS81IL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed